Login

Progression to Insulin Therapy in Patients With Type 2 Diabetes - Dr. Peter Kokkinos, Mayo Clinic 00:00:00

Share On Facebook Share On Twitter

Progression to Insulin Therapy in Patients With Type 2 Diabetes

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Come join 900+ alumni who have launched their own startups, raised $220+M in venture funding and who work with leading technology|Anastasia Cifuentes,Founding Partner,Neruda Ventures
00:10:00
Live 401(k) Review: Understanding Target Date Funds, Asset Allocation, and Fee Avoidance
00:10:00
Harry Barr, CEO of New Age Metals, Talks VRIC 2024 on RCTV with Mark Bunting | HARRY BARR - CHAIRMAN, CEO & DIRECTOR of New Age Metals
00:10:00
Nick Tulloch, CEO of Voyager Life PLC, on Navigating CBD Regulations and the Power of Digital Marketing | Nick Tulloch, CEO, Voyager Life PLC.
00:10:00
BrightView Holdings CEO Andrew Masterman on IPO, Employment, Immigration, and Economic Outlook
00:10:00
Why Choose Dunn Capital Management?
00:10:00
Understanding Grand Strategy: A Historical Perspective
00:10:00
Unveiling Financial Reporting Challenges with Dan Crowley from AVADA Group | Dan Crowley, CEO , Avada Group Ltd.
00:10:00
Ryan Hickey on Driving Growth in Financial Services | Ryan Hicke, CEO ,  SEI Investments Company.
00:10:00
Interview with Jimmy Lin: New Horizons Capital at the One-to-One Mining Conference
00:10:00
Nicolas Schweizer, CEO of Schweitzer Electronic, envisions a thriving future for the PCB industry in Europe.
00:10:00
Xanadu Mines Advances Prefeasibility Study with Key Developments in 2024

© 2026 Nehu